" class="no-js "lang="en-US"> Cambridge Enterprise - Medtech Alert
Saturday, September 20, 2025
Cambridge Enterprise | Pharmtech Focus

Cambridge Enterprise

About Cambridge Enterprise

Cambridge Enterprise

Cambridge Enterprise is the commercialisation arm of the University of Cambridge. At Cambridge Enterprise, we help academics achieve the impact that is central to securing long-term funding for research. Our success is measured in the success of our University partners as they bring their work to market, be it ground-breaking stem cell research, critical suspension technology used in Formula 1 racing, or a flower seed mix to enable bees to flourish and crops grow. We’re here to make the world a better place by helping to create a legacy of products, services and advice that benefit not just the University and the UK, but everyone.

Related Story

Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer

June 15 2022

Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate […]